Plunkett Research Online: Eli Lilly and Company

ELI LILLY AND COMPANY (LLY:NYS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology......



Eli Lilly and Company
Ticker: LLY
Exchange: NYS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 317 276-2000
Fax:
Address: Lilly Corporate Center
Indianapolis, IN 46285 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Discovery & Development
Pharmaceuticals
Drug Development
Drug Discovery
Drug Production
Contacts Description
Jacob Van Naarden CEO, Divisional/President, Divisional/Senior VP, Divisional
David Ricks CEO/Chairman of the Board/Director/President
See More
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology......See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Humalog
Trulicity
Forteo
Cymbalta
Zyprexa
Alimta
Olumiant
Promoter Technologies
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: